Organigram CEO Joins Canadian Chamber of Commerce Board of Directors
October 30 2020 - 6:00AM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce that
the Company’s Chief Executive Officer, Greg Engel, has accepted a
position on the Board of Directors of the Canadian Chamber of
Commerce.
The Canadian Chamber of Commerce is Canada's largest and most
recognized business association in the country, which speaks with
one unified voice on behalf of nearly a quarter million businesses.
Since 1925, the Chamber has connected businesses of all sizes, from
all sectors and from all regions of the country to advocate for
public policies that will foster a strong, competitive economic
environment that benefits businesses, communities and families
across Canada.
The role of the Canadian Chamber of Commerce Board of Directors
is to provide oversight for the business of the Canadian Chamber
and advise on its financial transactions. The board of directors is
also responsible for the implementation, interpretation and
promotion of policies approved by the organization’s membership.
Mr. Engel will serve on the Member Relations & Services
Committee.
“The appointment of Mr. Engel to the board of directors
recognizes the increasing importance of the regulated cannabis
industry to Canada’s economy, which is creating good, middle-class
jobs for Canadians across the entire country,” said Ryan Greer,
Senior Policy Director and Co-Chair, National Cannabis Working
Group of the Canadian Chamber of Commerce.
“I am proud to join the Canadian Chamber of Commerce’s Board of
Directors,” said Greg Engel, CEO, Organigram. “I look forward to
advocating not only on behalf of the Canadian cannabis industry but
also on behalf of each Canadian business that contributes every day
to our country’s economic and social landscape. I am pleased to
work alongside others who share a commitment to thriving businesses
and communities.”
For more information about the Canadian Chamber of Commerce,
please visit www.chamber.ca.
For more information about Organigram, please visit
www.orgranigram.ca.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201030005137/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024